How Canada Became a Midmarket Tech Destination
American investors were once a rare sight in Canada. Now, an increasing number are finding plenty of tech opportunities north of the border.
Sectors
SEC Chief Seeks Expanded Reporting Requirements on PE Funds | Middle-Market Public Policy Roundup
The SEC is exploring options to raise reporting requirements for private equity advisors, the Fed will keep its easy money policy in place, and the White House continues infrastructure talks.
How PEO Can Transform a Merger
Donna JW Hare, senior business consultant for Insperity, discusses the steps that deal-makers ignore at their own risk: human resources and reassuring employees.
Anti-SPAC Bill Surfaces in Hearing | Middle-Market Public Policy Roundup
A draft bill would remove protections for SPACs, the Fed warns of leveraged loan risk, and lawmakers barter over an infrastructure spending bill.
Patents as an Alternative Asset Class: A Financial Sponsor Perspective
Financial sponsors seeking investment diversification strategies can maximize returns by investing in high-quality patent portfolios.
How to Avoid Currency Risk When Investing Abroad
Sean Coakley of Cambridge Global Payments describes how to address foreign exchange risk during cross-border deals.
How Middle-Market Companies Can Prepare for Natural Disasters on the Heels of COVID-19
As mid-sized businesses transition to the new normal, they must continue to be vigilant and prepare for natural disasters.
Fed Governor Allays Inflation Fears | Middle-Market Public Policy Roundup
A high-ranking member of the Fed quelled inflation fears, the House will hold a SPAC hearing, and the SEC's next Government-Business Forum will focus on small and emerging funds.
Fed Maintains Rate in Spite of Early Signs of Overheating | Middle-Market Public Policy Roundup
The Fed holds interest rates despite overheating signs, Treasury Secretary Yellen withdraws comments on fiscal policy, and research supports PE-backed hospitals.
It’s the Small Things: Trends in Health Care
From increased regulation on pharmaceuticals to diseases diagnosed by AI, check out these and other trends shaping the health care industry.